SBIR/STTR Research Award
SMARTPLATE TECHNOLOGY FOR ADVANCED CELLULAR STAC M
Award amount
$1,499,740Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CFD Research Corporation
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- V3KCP1HNFM33
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
This project will develop design fabricate test and demonstrate a novel SmartPlate Technology for Advanced Cell based Models STAC M The STAC M technology will be demonstrated for both current static culture and next generation cell based assays The proposed effort features a collaboration between CFD Research Corporation and Vanderbilt University and builds on several critical elements already available and demonstrated by the proposing team in particular VU developed microformulator which features a combination of low cost micropumps and valves for control and CFD developed SynVivo microfluidic devices for cell based assays The developed technologies will reduce the cost and time inefficiencies associated with the drug development process The technologies can also be used for personalized medicine applications by created an organized or disease environment on an individualized basis in an vitro environment
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Multiphysics Modeling Framework for Raindrop-Induced Material Damage
- Ground Technologies for Surface Operation Risk Mitigation
- Supportive Tactical Aide Foresight Framework (STAFF)
- Soil Cohesion Effects on Cratering and Transport of Regolith due to Plume-Surface Interaction
- Modular and Scalable Machine Learning Framework for Infrared Search and Track
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
947 SBIR/STTR records share this UEI (1987–2026). Reported award amounts total $350,893,199. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce, Department of Energy